$51M HIV drug fraud in Jacksonville: five arrested in Medicare and Medicaid scheme
Five people face federal charges over a Jacksonville healthcare fraud involving more than 20,000 bogus HIV drug prescriptions, costing Medicare and Medicaid over $24 million.

Jacksonville pharmacy at centre of $51 million HIV drug fraud, DOJ says
Two men have been indicted in connection with a Jacksonville healthcare fraud scheme that generated more than 20,000 fraudulent claims for HIV medication, resulting in $51 million in payments, the U.S. Department of Justice announced on Thursday, as reported by wusf.org.
The indictments name Charles Bernard Griffin, who operated a Jacksonville pharmacy called First Coast Community Development, and St. Johns County accountant Ethelbert Chinenye Nwangbo. Both are awaiting trial. Prosecutors are seeking the forfeiture of more than $37 million from the two men in connection with money laundering, according to Gregory Kehoe, U.S. Attorney for the Middle District of Florida.
Three others charged earlier in the investigation — pharmacist Albert Dwayne Chester, marketer Jonathan Gholston, and nurse practitioner Rashan Jones — have already signed guilty pleas. Chester agreed to plead guilty to healthcare fraud; Gholston and Jones pleaded guilty to conspiring to defraud Medicare and Medicaid.
The scheme, which ran from November 2023 through late 2025, was designed to defraud Medicare, Medicaid and affordable healthcare insurers. At its core: prescriptions for HIV post-exposure prophylaxis (PEP) were arranged for people who had no medical need for the drugs and were never examined by a healthcare professional.
"All of these prescriptions — and there were well over 20,000 of them — were issued when there was no medical-patient relationship with the individuals who received these medications," Kehoe said at a news conference Thursday.
Investigators determined that a company called Smooth Vision Marketing was recruited in November 2023 to identify Medicare and Medicaid beneficiaries. The recruitment method was straightforward: potential patients were lured in with offers of government-sponsored mobile phones. Personal and insurance details were then collected through questionnaires at Griffin's pharmacy.
Griffin's pharmacy paid Gholston's marketing company $200 for each referral that led to an insurance payment. Gholston in turn paid individual marketers $50 per prescription. Chester generated the prescriptions, while Jones signed off on orders without ever speaking to the patients concerned.
"And what did they tell the agents? They never asked for it; they never wanted it," Kehoe said. "But oftentimes, it was delivered to them."
PEP drugs cost approximately $4,000 per month per patient, Kehoe noted, adding that the scheme put recipients' lives at risk by providing medication they did not need.
The financial breakdown, as outlined by Kehoe, shows Medicare losses of approximately $11.5 million and Medicaid losses of around $12.5 million. Griffin received roughly $14 million in fraud proceeds, Chester approximately $5 million, Gholston around $2 million, and Jones more than $400,000.
FBI, IRS and other federal agencies led the investigation. To date, investigators have seized eight properties and six vehicles linked to the scheme.
Isaac Bledsoe, Agent-in-Charge of the Inspector General's Office, stressed the broader consequences of such fraud at Thursday's news conference. "Those are precious safety net resources meant for medically necessary health services for eligible enrollees," he said. "Healthcare fraud undermines both the integrity of federal healthcare programs like Medicare and Medicaid and the trust that the American public places in our entire healthcare system."
Source: Google News MT — Crime (en)